{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:03:26Z","timestamp":1748059406153,"version":"3.41.0"},"reference-count":22,"publisher":"Endocrinology Research Centre","issue":"2","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>Congenital adrenal hyperplasia (CAH) encompasses a group of autosomal recessive disorders characterized by defects in enzymes critical for steroidogenesis, with 21-hydroxylase deficiency due to mutations in the CYP21A2 gene being the most prevalent form.<\/jats:p><jats:p>Since the introduction of replacement therapy and neonatal screening programs in the 1950s, there has been a significant increase in survival rates among newborns diagnosed with CAH. However, despite these advancements, mortality associated with this condition remains disproportionately high. Achieving optimal therapeutic compensation through medication remains a complex challenge, contributing to a range of long-term complications. These complications stem from both the underlying disease and its treatment, impacting key physiological functions, including metabolism, growth and development, cardiovascular health, and fertility. These multifaceted outcomes underscore the need for ongoing research and the refinement of therapeutic approaches to better manage this intricate condition. This article presents a series of four clinical cases of CAH characterized by the absence of sustained compensation for glucoand mineralocorticoid deficiencies. These cases were further complicated by the development of large adrenal masses and ectopic testicular adrenal rest tissue (TART), emphasizing the challenges in achieving long-term disease management.<\/jats:p>","DOI":"10.14341\/probl13564","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:37:53Z","timestamp":1747841873000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":0,"title":["Difficulty with differential diagnosis on adrenal lesions in congenital adrenal cortex dysfunction: a series of clinical cases"],"prefix":"10.14341","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5592-4794","authenticated-orcid":true,"given":"A.","family":"Chevais","sequence":"first","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-9454","authenticated-orcid":true,"given":"N. V.","family":"Tarbaeva","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-4429","authenticated-orcid":true,"given":"Y. Y.","family":"Golubkina","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0918-0544","authenticated-orcid":true,"given":"M. M.","family":"Gadzhimuradova","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-7809","authenticated-orcid":true,"given":"K. V.","family":"Ivashchenko","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-7060","authenticated-orcid":true,"given":"D. O.","family":"Ladygina","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University (Sechenov University)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9124-294X","authenticated-orcid":true,"given":"M. V.","family":"Vorontsova","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre; Lomonosov Moscow State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-5732","authenticated-orcid":true,"given":"O. B.","family":"Bezlepkina","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-7877","authenticated-orcid":true,"given":"G. A.","family":"Melnichenko","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-9742","authenticated-orcid":true,"given":"N. G.","family":"Mokrysheva","sequence":"additional","affiliation":[{"name":"Endocrine Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, et al. Congenital adrenal hyperplasia. Lancet. 2023;401(10372):227-244. doi: https:\/\/doi.ru\/10.1016\/S0140-6736(22)01330-7","DOI":"10.1016\/S0140-6736(22)01330-7"},{"key":"ref2","unstructured":"Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline [published correction appears in Journal of Clinical Endocrinology & Metabolism 2019 Jan 1;104(1):39-40. doi: 10.1210\/jc.2018-02371]. Journal of Clinical Endocrinology & Metabolism. 2018;103(11):4043-4088. doi: https:\/\/doi.ru\/10.1210\/jc.2018-01865"},{"key":"ref3","unstructured":"Kareva MV. Vrozhdennaya disfunkciya kory nadpochechnikov u detej: epidemiologiya, geneticheskaya osnova, personalizirovannyj podhod k diagnostike i lecheniyu, monitoring somaticheskogo i reproduktivnogo zdorovya. [dissertation] Moscow; 2019. (in Russ.) \u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043f\u043e: https:\/\/www.endocrincentr.ru\/sites\/default\/files\/specialists\/science\/dissertation\/kareva_doctorskaya_ final_26_11_18.pdf"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Mokrysheva NG, Melnichenko GA, Adamyan LV, et al. Russian clinical practice guidelines \u00abcongenital adrenal hyperplasia\u00bb. Obesity and metabolism. 2021;18(3):345-382. (In Russ.). doi: https:\/\/doi.org\/10.14341\/omet12787","DOI":"10.14341\/omet12787"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline [published correction appears in J Clin Endocrinol Metab. 2019 Jan 1;104(1):39- 40. doi: 10.1210\/jc.2018-02371]. J Clin Endocrinol Metab. 2018;103(11):4043-4088. doi: https:\/\/doi.ru\/10.1210\/jc.2018-01865","DOI":"10.1210\/jc.2018-01865"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Shifman BM, Dzeranova LK, Pigarova EA, et al. Late consequences of classic congenital adrenal hyperplasia and its long-term poor control in men (case report and literature review). Obesity and metabolism. 2019;16(4):90-102. (In Russ.). doi: https:\/\/doi.org\/10.14341\/omet10032","DOI":"10.14341\/omet10032"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Nermoen I, Falhammar H. Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Endocr Pract. 2020;26(11):1351-1365. doi: https:\/\/doi.ru\/10.4158\/EP-2020-0058","DOI":"10.4158\/EP-2020-0058"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"El-Maouche D, Hannah-Shmouni F, Mallappa A, et al. Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clin Endocrinol (Oxf ). 2019;91(2):247-255. doi: https:\/\/doi.ru\/10.1111\/cen.13996","DOI":"10.1111\/cen.13996"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Reisch N, Scherr M, Flade L, et al. Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010;95(5):2065-2072. doi: https:\/\/doi.ru\/10.1210\/jc.2009-1929","DOI":"10.1210\/jc.2009-1929"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kim TM, Kim JH, Jang HN, Choi MH, Cho JY, Kim SY. Adrenal Morphology as an Indicator of Long-Term Disease Control in Adults with Classic 21-Hydroxylase Deficiency. Endocrinol Metab (Seoul). 2022;37(1):124-137. doi: https:\/\/doi.ru\/10.3803\/EnM.2021.1278","DOI":"10.3803\/EnM.2021.1278"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Calissendorff J, Juhlin CC, Sundin A, et al. Adrenal myelolipomas. Lancet Diabetes Endocrinol. 2021;9(11):767-775. doi: https:\/\/doi.ru\/10.1016\/S2213-8587(21)00178-9","DOI":"10.1016\/S2213-8587(21)00178-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sahlander F, Patrova J, Mannheimer B, Lindh JD, Falhammar H. Congenital adrenal hyperplasia in patients with adrenal tumors: a population-based case-control study. J Endocrinol Invest. 2023;46(3):559-565. doi: https:\/\/doi.ru\/10.1007\/s40618-022-01933-0","DOI":"10.1007\/s40618-022-01933-0"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"\u0141ebek-Szata\u0144ska A, Nowak KM, Samsel R, et al. Adrenocortical carcinoma associated with giant bilateral myelolipomas in classic congenital adrenal hyperplasia. Pol Arch Intern Med. 2019;129(7-8):549-550. doi: https:\/\/doi.ru\/10.20452\/pamw.14788","DOI":"10.20452\/pamw.14788"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lib\u00e9 R, Arlt W, Louiset E, et al. A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014;99(6):1943-1944. doi: https:\/\/doi.ru\/10.1210\/jc.2014-1342","DOI":"10.1210\/jc.2014-1342"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Pakalniskis MG, Ishigami K, Pakalniskis BL, et al. Adrenal collision tumour comprised of adrenocortical carcinoma and myelolipoma in a patient with congenital adrenal hyperplasia. J Med Imaging Radiat Oncol. 2020;64(1):67-68. doi: https:\/\/doi.ru\/10.1111\/1754-9485.12961","DOI":"10.1111\/1754-9485.12961"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Gemmel F, Bruinsma H, Oomen P, et al. PET\/CT incidental detection of bilateral adrenal myelolipomas in a patient with a huge maxillary sinus carcinoma. Clin Nucl Med. 2010;35(2):132-133. doi: https:\/\/doi.ru\/10.1097\/RLU.0b013e3181c7c007","DOI":"10.1097\/RLU.0b013e3181c7c007"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Elaini AB, Shetty SK, Chapman VM, et al. Improved detection and characterization of adrenal disease with PET-CT. Radiographics. 2007;27(3):755-767. doi: https:\/\/doi.ru\/10.1148\/rg.273055031","DOI":"10.1148\/rg.273055031"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ludwig V, Rice MH, Martin WH, et al. 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography uptake in a giant adrenal myelolipoma. Mol Imaging Biol. 2002;4(5):355-358. doi: https:\/\/doi.ru\/10.1016\/s1536-1632(02)00018-5","DOI":"10.1016\/S1536-1632(02)00018-5"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Castinetti F, Verschueren A, Cassagneau P, et al. Adrenal myelolipoma: an unusual cause of bilateral highly 18F-FDG-avid adrenal masses. J Clin Endocrinol Metab. 2012;97(8):2577-2578. doi: https:\/\/doi.ru\/10.1210\/jc.2012-1713","DOI":"10.1210\/jc.2012-1713"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Engels M, Span PN, van Herwaarden AE, et al. Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment. Endocr Rev. 2019;40(4):973-987. doi: https:\/\/doi.ru\/10.1210\/er.2018-00258","DOI":"10.1210\/er.2018-00258"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Stikkelbroeck NM, Hermus AR, Suliman HM, et al. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab. 2004;17(4):645-653. doi: https:\/\/doi.ru\/10.1515\/jpem.2004.17.4.645","DOI":"10.1515\/JPEM.2004.17.4.645"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Falhammar H, Filipsson H, Holmdahl G, et al. Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr J. 2009;56(4):601-608. doi: https:\/\/doi.ru\/10.1507\/endocrj.k08e-312","DOI":"10.1507\/endocrj.K08E-312"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13564\/10855","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:51:27Z","timestamp":1747997487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5,20]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13564","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"type":"electronic","value":"2308-1430"},{"type":"print","value":"0375-9660"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}